POZN:Q&A Exclusive: POZEN's Team Confident About Building Shareholder Value in 2012 and Beyond
PPS: $4.27
LOS ANGELES, CA--(Marketwire -01/11/12)- It's rare to find a President and Chief Executive Officer of any big board traded company listed as the firm's biggest shareholder. It's refreshing and it's just one of the reasons why we believe the management team at the pharmaceutical firm, POZEN (NASDAQ: POZN - News), is extra focused and driven to perform well for its investors.
Market Data 
Markets 
AI
